THE EFFECT OF TWO FRUIT EXTRACTS AND DRUGS ON THE LIVER OF ALBINO MICE WITH INDUCED LEISHMANIASIS

Size: px
Start display at page:

Download "THE EFFECT OF TWO FRUIT EXTRACTS AND DRUGS ON THE LIVER OF ALBINO MICE WITH INDUCED LEISHMANIASIS"

Transcription

1 THE EFFECT OF TWO FRUIT EXTRCTS N RUGS ON THE LIVER OF LINO MICE WITH INUCE LEISHMNISIS Kawthar I.F. l-harmni*, Zohair I.F. Rahemo* and Hussain I.. l-khan** * University of Salahaddin, Erbil, Kurdistan, Iraq **epartment of iology, College of Science, University of Mosul, Mosul, Iraq *( zohair_rahemo@yahoo.com) STRCT mong 117 of the albino mice used in this study, 108 were intraperitionally infected with 100 X 106 promastigotes of Leishmania donovani (MHOM\ IQ\ 982\ RCI) strain, while the rest groups (9) were left without infection. The inoculation of albino mice caused the elevation of liver and spleen weight after 7-15 days and the treated mice with 20 mg/kg by Pentostam and llupurinol for 10 and 15 days caused elevation of liver and spleen weight, whereas the treated mice with 20 mg\kg for 20 days restored the liver and spleen weight near to normalization. The treated mice with mg\kg from Melia azedarach and mg\kg from Citrus colocynthis caused depletion of the average liver and spleen weight in comparison to the control positive. Histological examination of liver sections revealed that high concentration of two aqueous fruits extract returns the liver tissues towards the normalization. mong the most important histopathologcal results: In positive control scattered necrosis, lymphatic infiltration, proliferation of macrophages and with a variable number of leishman bodies were observed. In 20 mg/kg Pentostam-allupurinol for 10 days: multifocal necrosis, presence of Kupffer cells and macrophages colonized with leishman bodies, while in same concentration but for 20 days sinusoid dilataion, scattered multifocal necrosis were observed.in a concentration of M. azadarach 20 mg/kg : hyperplasia of phagocytic cells containing leishman bodies were seen, while in 40 mg/kg focal necrosis and inflammatory cells were revealed, but in mg/kg lymphatic infiltration, few mixed inflammatory cells infiltration were observed. In concentration of C. colocynthis 20 mg/kg central vein dilatation, multicemal necrosis, diffuse lymphatic infiltration and the presence leishman bodies can be distinguished, while in 40 mg/kg multifocal necrosis, diffuse lymphatic infiltration and the presence of leishman bodies were seen, in 60 mg/kg lymphatic infiltration only was distinguished, while in mg/kg liver return to normal histology. Key words: histopathology, liver, plants extracts. INTROUCTION Leishmaniasis is endemic in 88 countries with an estimated 350 million people at risk and 12 million people are affected (WHO, 2001; Tiuman et al., 2005; Singh, 2006; Mishra, et al., 2007). L. donovani complex causes visceral leishmaniasis(vl) or kala azar, while the L. tropica complex induces cutaneous leishmaniasis or oriental sore in the old world and L. mexicana complex causes cutaneous disease in Latin merica and L. braziliensis complex caused mucocutaneous disease in merica (Chan acab and Pena Rodriguez, 2001; Croft and Coombs, 2003).VL is the most severe clinical form of the disease (Singh, 2006).Pentavalent antimonials, the drug of choice have been successfully used for treatment of kala azar and has serious side effects, and requires a prolonged course of treatment it has been losing its efficacy in some regions due to increasing parasite resistance, and causes renal and cardiac toxicity (Croft and Yardley, 2002; Murray, 2004b; Ferreira et al., 2004; renzan et al., 2007). Pentamidine was used as a second choice for the treatment, which also may has serious side effects and acquired resistance even with prolonged dosage. llopurinol found to be more effective with little toxicity for treating leishmaniasis as used clinically as antigout drug, against promastigotes of L. tropica (Zgaeir, 1999). combination of llopurinol was more effective in leishmaniasis, combination was possible to reduce the duration of treatment and produces better results than antimony alone or allopurinol alone (as et al., 2001; Join er et al., 2005). Natural products have potential in search for new and selective agents for treatment of important tropical diseases.the plant kingdom is undoubtedly valuable as a source of new medicinal agents (Rocha et al., 2005), alkaloids, terpenes, quinones, chalcones, lactones and saponins are known as antiprotozoal products (Wright and Philipson, 1990).Crude extracts from lstonia macrophylla, Rhazya stricta, Triclisia patens showed strong activity against promastigote forms of L. donovani with.these extracts have stronger cytotoxic effect on the parasite than on mammalian cells (Camacho et al., 2003).The linalo rich essential oil from the leaves of Croton cajucara showed excellent inhibition of the growth of promastigote and amastigote forms of L. amazonensis (Rosa et al., 2003). Two extracts of two plants naturally cultivated in Iraq were selected to test their lethal effects on Leishmania donovani induced experimental albino L/C mice. These are the Chinaberry, M. azedarach and the bitter apple, Citrullus colocynthis as usually natural plants have less side effect compared to synthetic drugs. The aims of the present study: 1 etermining the effect of two aqueous fruit extracts M. azedarach and C. colocynthis on induced visceral leishmaniasis in L /c mice and comparing their effects with the combination of two standard drugs, namely Pentostam and llopurinol. 2 Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 16

2 etermining the effect of these two plant extracts on average liver and spleen weight. 3-Histopathological changes in the liver. MTERILS N METHOS strain of Leishmania donovani (MHOM / IQ / 1982 / RC1) provided l Nahreen University, aghdad. This stock culture was cultivated in iphasic medium (NNN).dult male L /c mice Mus musculus, gm, 6 8 weeks old were used for the pharmacological and histological studies. They were housed in controlled environment, the room temperature was maintained at 25 ± 2 C and 10 hr dark /14 light cycle with standard laboratory diet. Leishmania promastigotes were cultivated on NNN medium (Jawdat et al., 1985). NNN medium consists of two phases: solid phase, blood agar, and liquid phase Lock ś solution left out to cool off until antibiotics added (0.1mg / ml streptomycin, IU penicillin. One gram of dried extract fruits of M. azedarach and C. colocynthis, were dissolved in 5 ml.w. (total concentration 200 mg / ml as a stock culture).concentration 20, 40, 60, 80 and 100 mg / kg WT were prepared from the stock culture according to the procedure described by Riose et al. (1987). Sodium stibogluconate (Pentostam, Sb) prepared as aqueous solution: Each ml of the solution containing 100 mg pentostam, the stock solutions were freshly prepared and sterilized using millipore filter 0.22µ and injected either intramuscularly (IM) or intraperitoneally (IP). llopurinol (Urizol). Hpp.: Each tablet of allopurinol contains 100 mg allopurinol, dissolved one tablet in 100 ml. W. The concentration of the solution becomes 1mg / ml. The recommended dose of allopurinol for treatment of leishmaniasis was 20 mg / kg / day for days. One hundred and seventeen male L/c mice 6 to 8 weeks old were used in these experiments. 108 mice were intraperitoneally infected with promastigotes in stationary phase. The rest of mice were left without infection as control negative (con ve). The animals were divided into five groups as follows (Table 1): (1) The first group consists of 3 sub-groups : 3 animals for each sub group and were used to evaluate the therapeutic effect of Pentostam and allopurinol. Treatment with 20 mg / kg body weight / day was started 20days post infection. Each animal received 10 doses in the first sub group for 10 days. 15 doses in the second sub group for 15 days and 20 doses in the third sub group for 20 days, animals of these sub groups sacrificed 10, 15 and 20 days post infection, respectively. (2) The second group consists of 3 subgroups (15 animals for each sub group) were used to evaluate the plant extract of M. azedarach. Each animal received 10 doses in the first sub group, 15 doses in the second subgroup and 20 doses in the third subgroup, each sub groups received five different doses of the extract 20, 40, 60, 80 and 100mg / kg body weight orally.the animals of these sub groups were sacrificed 10, 15 and 20 days post infection, respectively. The post necropsy procedure was followed as in the first group (Table.3). (3) The third group was as the second group except that the plant extract was C. colocynthis used instead of M. azedarach. (4) The fourth group was consisted of noninfected untreated animals (n=9) which were left as a negative control (con ve)group and sacrificed at 10, 15 and 20 days later and subjected to the same procedure. (5) The fifth group was consisted of infected un treated animals (n = 9). This group served as positive control (con + ve). On the10 th, 15 th and 20 th day. t the end of the experimental period, after 10, 15 and 20 days the animals were sacrificed, various biochemical and haematological parameters were estimated. Table 1: No. of animals used, and the concentrations Melia azedarach and Citrullus colocynthis (20mg/kg 100mg/kg). Treatments (mg / kg bwt) uration of treatment(days) No. of animals Control ( ) Control (+) Pen/ll.20mg/kg Melia 20 mg/kg Melia 40 mg/kg Melia 60 mg/kg Melia 80 mg/kg Melia 100 mg/kg Citrullus20 mg/kg Citrullus40 mg/kg Citrullus60 mg/kg Citrullus80 mg/kg Citrullus100 mg/kg Total Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 17

3 For Histological studies: Liver tissues fixed in 10 % formaldehyde for 24 hrs for histopathological observation. The prepared 5 micron thick sections were stained with hematoxyline and eosin (H/E)( see Lee and Luna, 1960). RESULTS N ISCUSSION s shown in Table.2 and after Using the aqueous fruit extract of M. azedarach at the concentration 20mg / kg did not control the leishmanial growth for 10, 15, and 20 days, but using the aqueous fruit extracts at the concentration 40, 60, 80 and 100 mg / kg control the growth in infected mice for the same period of time, while the aqueous fruit extracts of C. colocynthis at the concentration 20 and 40 mg / kg did not control the leishmanial growth, but at the concentration 60, 80 and 100 mg / kg controlled the visceral leishmaniasis in liver and spleen of infected mice at the same period of time. This result indicates that the two aqueous fruit extracts of the two plants have inhibitory effect on the growth of VL in albino mice in vivo, and the con 40mg / kg Melia is equivalent to 60mg / kg of Citrullus extract. Table.2: The effect of different concentrations of M. azedarach and C. colocynthis extracts on the liver and spleen of infected mice with v. leishmaniasis in the inoculated cultures and comparison with pentostam and allopurinol, sacrified at 10, 15 and 20 days post infection. Treatments (mg / kg) Results of inoculated cultures Growth No. of animals Liver (days) Spleen (days) Cont (+) Pentostam and + + _ + + _ 9 llopurinol Melia 20 mg / kg Melia 40 mg / kg 9 Melia 60 mg / kg 9 Melia 80 mg / kg 9 Melia100 mg / kg 9 Citrullus20 mg /kg Citrullus40 mg /kg Citrullus60 mg / 9 kg Citrullus80 mg / 9 kg Citrullus100 9 mg/kg Total 108 ( + ) = Viable. ( ) = None viable. Table ( 3) showed the average weight of liver in infected mice (control positive, con + ve.).there was a significant variation in the average liver weight (P< 0.05) between the infected groups (con + ve.) for 10, 15 and 20 days were 1.79, 1.45 and 1.61g when compared with (con ve) were 1.29, 1.05 and 1.23 g respectively. These observations were supplemented with the presence of promastigotes in the inoculated cultures with the liver of infected mice after (5) days of inoculation. Our result also were confirmed with the histopathological examination of mice liver sections (Figs1, 2). The liver section in (con + ve.) with preserved general architecture, scattered necrosis, lymphocytic infiltration, proliferation of macrophages and clusters of macrophages often containing leishman bodies. (amastigote). This result revealed that, the average liver weight of infected mice with L. donovani promastigotes were increased in the first week then decreased in weight after this period of time. This result is in agreement with the confirmed previous experiments of Molan et al.(1989) who observed that the albino mice showed a remarkable increase in liver weight. This increasing was at its peak at the first seven days post injection, then the liver weight decreased after this Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 18

4 Table 3: The effect of different concentrations of aqueous fruit extracts of M. azedarach and C. colocynthis on liver weight (g) of mice infected with L.donovani in comparison with pentostam and allopurinol, sacrificed 10, 15 and 20 days post infection. uration (day) Treatments (mg/kg) Mean SE Cont ** Cont Ef * e * Pent /llo 20 mg/kg Cd * ** Melia 20 mg/kg G * Fg ** e Melia 40 mg/kg E *** Cde ** C Melia 60mg/kg d Melia 80 mg/kg d Melia 100 mg/kg ** Citrullus 20 mg/kg F * G E Citr. 40 mg/kg Ef Citr. 60 mg/kg d * d * Citr. 80 mg/kg d * Citr.100 mg/kg *Means with different letters have significant difference at p<0.05 according to uncan test. *Significant differences of the 10 day at p<0.05, ** at p<0.01 and *** at p< period of time. This means that the liver weight increased according to the parasite number, and also is in agreement with l Harmni (1988) who showed that the promastigotes of L. donovani in mice and golden hamsters was accompanied by marked enlargement of both spleen and liver. This result also agree with those of Grun and Stauber (1957) and Stauber et al. (1958) as they observed that primarily increasing in the number of parasites of VL then decreased, this difference may be due to the various strains of parasites and the stains of albino mice. This result also agree with l Shanawi (1975) who observed similar results. There were increasing average of liver weight of treated mice with combined drugs for 10 and 15 days 1.43, 1.33 g when compared with the normal groups (con ve ),1.29, 1.05 g. ut the treated mice for 20 days showed a decreased in the average liver weight to 0.85g in comparison with the normal group 1.23g and a significant variation (P < 0.01) between the mice treated with combined drugs for 20 days with these treated for 10 days. This indicates that the treatment with combined drugs for 10 and 15 days did not control the parasite. These observations were supplemented with the presence of promastigotes with the liver. However the number of promastigotes in cultures less than the numbers of promastigotes in inoculated cultures with the liver of (con + ) groups. The result also were supplemented with the histopathological examination (Fig.3), the liver section with multifocal necrosis, Kupffer cells and macrophages colonized by leishman body. ut the treated mice with the combined drugs for 20 days controlled the parasite completely. This result confirmed by the absence of promastigotes in inoculated cultures and the liver section with sinusoidal dilatation,scattered multifocal necrosis and without the leishman body (Fig.4). The treatment for a long time associated adverse side effects during a lengthy and painful treatment course (Reithinger et al., 2005: Sundar and Chatterjee, 2006: Colakoglu et al., 2006). ntileishmanial chemotherapy can have adverse effects and may fail to cure patients (Mosleh et al., 2008).It was well known that the result observed was in agreement with those of Goodwin (1945) who found that the experimental animals infected with VL and treated with low doses of Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 19

5 Pentostam increased the infection when compared with the (con + ve).similar results were obtained by l-khateeb et al.(1977). The result was also in agreement with Zgaeir ( 1999) who used llopurinol combined with Pentostam of the same concentrations on L. donovani and L. tropica in vitro, showed actually a synergistic effect which decreased the growth of parasite more than using llopurinol or Pentostam alone. The combination of llopurinol with antimony produced better results than each one alone for treatment of leishmaniasis (enerolle and ourdoiseau, 1999). The results observed in this study are in agreement with confirmed previous study, and also agree with the study reported by silian et al.(2004) Table (2) also showed the average liver weight in mice infected (I P) with 100X 10 6 promastigotes of L. donovani and treated with aqueous extract of M. azedarach in different concentrations 20, 40, 60, 80 and 100 mg / kg.there was a significant variation (P< 0.05) in the average liver weight of treated mice with 20 mg / kg from the extract were 2.1,1.6,1.7 g when compared with the average liver weight of (con ve ) group 1.29, 1.05 and 1.23 g for 10,15 and 20 days respectively. These observations were supplemented by the presence of promastigotes in the inoculated cultures with a piece of the liver of this group. ut the number of promastigotes in positive culture was less than the number of promastigotes in cultures inoculated with the liver of (con + ve) and the histopathological sections revealed the central vein dilatation, multifocal necrosis, diffuse lymphocytic infiltrations, hyperplasia of phagocytic cells containing leishman body (Fig.5)These results indicates a possible role of hepatocytes as a parasite reservoir during the infection (Gangneux et al., 2005). The liver weight of treated mice decreased with different concentration of aqueous Melia extracts 40, 60, 80 and 100 mg /kg for 10,15 and 20 days, then the decreased liver weight was restored towards the normalization and with nonsignificant variation when compared with the average liver weight of (con ve ).This result was supplemented by the absence of promastigotes in inoculated liver culture and the histopathological examination of liver sections with normal view. The liver of treated mice with 40 mg / kg of the Melia extract with few focal necrosis and inflammatory cells (Fig.6), but treated mice with 60 mg / kg show few piecemeal necrosis few mixed inflammatory cells infiltration (Fig.7), more wide spread necrosis and diffuse lymphocytic infiltration (Fig.8).The treated mice with 80 and 100mg / kg showed more diffuse necrosis and mixed inflammatory cells infiltration (Figs. 9,10). s shown in Table (3) there was a significant variation (P<0.05) in the average liver weight of treated mice with 20 and 40 mg / kg after applying the extract for 10, 15 and 20 days when compared with the average liver weight of (con ve). This result was supplemented by demonstration of promastigotes in the inoculated cultures with a piece of the liver of these groups. However the number of promastigotes in cultures was milder than the number of promastigotes in (con + ve) cultures. The histopathological sections include central vein dilatation, multifocal piecemeal necrosis, diffuse lymphatic infiltration and the presence of intracellular amastigotes (Figs.11, 12). In the treated mice with 60, 80, and100 mg / kg of the C. colocynthis extract the liver weight decreased and then restored towards the normalization, this result was confirmed by the absence of promastigotes in inoculated cultures and the histopathological examination of the liver sections with lymphocytic infiltration and appear with a normal view and no signs of amastigotes (Figs.13-16). The present results revealed that the combination of Pentostam and llopurinol in concentrations of 20 mg / kg/ for 20 days showed effectiveness against VL, but the treatment with lower doses show no encouraging results. Jha (2006) reported that these drugs are potentially toxic and often ineffective and have serious side effects and acquired resistance even with prolonged dosage when used as a monotherapy. The aqueous fruit extracts of M. azedarach and C. colocynthis were found to show a significant activity against VL and had stronger cytotoxic effects on the parasite than on mammalian cells which controlled the disease without any side effects on the host and did not result in any change in general behavior of the animals. s shown in Table (4) there was a significant variation (P<0.05) in the average spleen weight of infected mice (con + ve) for 10,15 and 20 days were 0.36, 0.33 and 0.31 g when compared with (con ve)were 0.15, 0.12 and 0.09 g, respectively. Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 20

6 Table(4) showed significant variation (P<0.05) of the average spleen weight of treated mice with combined drugs for 10, 15 days were 0.27 and 0.28 g compared with the (con ve) groups, but with non significant variation with the average spleen weight treated for 20 days 0.07 g. The treatment of albino mice with low doses of combined drugs did not completely control the parasite and failed to give protection to mice against L. donovani infection.this result was confirmed by the presence of promastigotes in inoculated spleen of these groups but no appearance in the inoculated spleen of treated mice with combined drugs for 20 days. Table (4) showed an average spleen weight of mice infected (IP) with promastigotes of VL and treated with different concentrations 20, 40, 60, 80 and 100 mg / kg from aqueous fruit extract of M. azedarach for 10, 15 and 20days post infection. There was a significant variation (P<0.05) of average spleen weight of treated mice with 20 mg / kg from M. azedarach extract for 10, 15 and 20 days were 0.41, 0.32 and 0.27 g when compared with non infected mice 0.15, 0.12 and 0.09 g. Table 4: The effect of different concentrations of aqueous fruit extracts of M. azedarach and C. colocynthis on spleen weight (g) of mice infected with L. donovani in comparison with pentostam and allopurinol, sacrificed at 10, 15 and 20 days post infection. ion (day) Mean SE Treatments (mg/kg) Cont b * Cont G * C Pent. / llo C Efg * Melia 20 mg/kg * G * Melia 40 mg/kg C ** c-f *** b Melia 60mg/kg bc b Melia 80 mg/kg b bc b Melia 100 mg/kg b b Citrullus 20 mg/kg Fg * Citr. 40 mg/kg C d-g * Citr. 60 mg/kg b-e Citr. 80 mg/kg Citr.100 mg/kg a-d bc * Means with different letters have significant difference at p<0.05 according to uncan test. * Significant differences of the 10 day at p<0.05, ** at p<0.01 and *** at p< b * b Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 21

7 C.V Figure 1: Liver section of mice (control negative), sacrificed 15days post infection (H +E 100X) C.V.: central vein. Figure 2: Liver section of mice (control positive) sacrificed 15 days post infection (H +E 1000X). L..: Leishman body S. Figure 3: Liver section of mice, treated with pentostam and allopurinol, sacrificed 10 days post infection (H +E 1000X). KC: Kupffer cell., L..: Leishman body. L. Figure 4: Liver section of mice, treated with pentostam and allopurinol, sacrificed 20 days post infection (H +E 400X).S..: Sinusoidal dilatation. Figure 4.5: Liver section of mice, treated with Melia azedarach 20mg / kg and sacrificed 15 days post infection (H +E 1000X). L..: Leishman body. Figure 4.6: Liver section of mice, treated with Melia azedarach 40mg / kg and sacrificed 15 days post infection (H +E 1000X). INF.c.: Inflammatory cells, N.: Necrosis. Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 22

8 Figure 7: Liver section of mice, treated with Melia azedarach 60mg / kg and sacrificed 15 days post infection (H +E 1000X). Figure 8: Liver section of mice, treated with Melia azedarach 60mg / kg and sacrificed 15 days post infection (H +E 100X). P.S.: Portal Space, Infl.C. :Inflammatory Cell, C.V.: Central Vein. Figure 9: Liver section of mice, treated with Melia azedarach 80mg / kg and sacrificed 20 days post infection (H +E 100X). P.S.: Portal space, C.V.: Central vein. Figure 10: Liver section of mice, treated with Melia azedarach 100mg / kg and sacrificed 15 days post infection (H +E 100X). INF.c.: Inflammatory cells. Figure 11: Liver section of mice, treated with Citrullus colocynthis 20mg /kg and sacrificed 15 days post infection (H +E 1000X). L..: Leishman body. Figure 12: Liver section of mice, treated with Citrullus colocynthis 40mg / kg and sacrificed 15 days post infection (H +E 1000X).L..: Leishman body. Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 23

9 C.V P.S Figure 13: Liver section of mice, treated with Citrullus colocynthis 60mg / kg and sacrificed 10 days post infection (H+E 400X). C.V..: Central vein, P.S.: Portal space. Figure14: Liver section of mice, treated with Citrullus colocynthis 60mg / kg and sacrificed 15 days post infection (H +E 100X). INF.c.: Inflammatory cells. Figure 15: Liver section of mice, treated with Citrullus colocynthis 80mg / kg and sacrificed 15 days post infection (H +E 100X). C.V.: Central vein, P.S.: Portal space. Figure16: Liver section of mice, treated with Citrullus colocynthis 100mg / kg and sacrificed 15 days post infection (H +E 100X). C.V.: Central vein, P.S.: Portal space. In addition to this, the positive cultures confirmed this. ut the spleen weight of treated mice with different concentration of M. azedarach 60, 80 and 100 mg / kg for 10,15 and 20 days showed no significant variations when compared with the average spleen weight of (con ve).this result indicated that the treatment of VL with M. azedarach were restored towards the normalization. In addition to this the absence of promastigotes in the cultures inoculated with the spleen of these groups. The previous result showed that the aqueous fruit extract of M. azedarach appears to offer a fruitful strategy for treatment of VL and also has a potential prophylactic and therapeutic efficacy against kala azar infection. Table (4) also showed the average spleen weight in infected albino mice treated with different concentrations 20,40,60,80 and 100 mg / kg of aqueous fruit extract of C. colocynthis.there was a significant variation (P< 0.05) in the average spleen weight of the treated mice with 20 and 40g / kg from the aqueous extract for 10,15 and 20 days when compared with the average spleen weight of (con ve). In addition to this, the positive cultures confirmed this, but with non-significant variation between the average spleen weight of treated mice with 60, 80 and 100 mg /kg for the same period of time when compared with the average spleen weight of (con ve).this result indicated that the treatment with C. colocynthis extract restore the spleen weight into normalization. The previous result showed that the infected mice with Kala azar and treated with 20mg / kg of combined drugs for 20 days consider as a good leishmanicidal agent. ut the two aqueous fruit extract of M. azedarach and C. colocynthis were more effective than the combined drugs for the treatment of VL in some concentrations mentioned before, the inoculated cultures of spleen and liver confirmed these observations. Such results are considered new for such kind of experimental study. Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 24

10 REFERENCES l-harmni K. I. (1988). The effect of ultraviolet irradiation on Leishmania donovani and evaluation of adioattenuated parasites in immunization of experimental animals. M.Sc. Thesis, Education College, Salahaddin University. L-Khateeb GH., l-jeboori., TI.and L-Janabi K. (1977). In vitro efficacy of some drugs on promastigotes of Leishmania donovani. Chemotherapy. 23 (4): l-shanawi, F. (1975). Comparison of the course of laboratory infection in some Iraqi rodents with an Iraqi strain of Leishmania donovani. M.Sc.Thesis, Science College, aghdad University and laboratory animals. silian., Sadeghinia., Faghihi and Momeni. (2004). Compartive study of the efficacy of combined cryotherapy and intralesional meglumine antimonite alone for the treatment of cutaneous leishmaniasis. J. ermatol. 43(4): renzan M., Nakamura C., Prado., Ueda-Nakmura T., Young M. and Cortez. (2007). ntileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol. Res. 101 (3): Camacho.R., Phillipson J.., Croft S L., Solis P. N., Marshall S. J. and Chazanfar S.. (2003). Screening of plant extract for antiprotozoal and cytotoxic activities. J. Ethnopharmacol 89: Chan-acab M. J. and Pena-Rodriguez L. M. (2001). Plant natural products with leishmanicidal activity. Nat Prod. Rep.,18: Colakoglu M., Yaylali G., Colakoglu N. and Yilmaz M. (2006). Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in patients with renal failure. Scand. J. Infect. is. 38 (2): Croft S. and Coombs G. (2003). Leishmaniasis, current chemotherapy and recent advances in the search for novel drugs. Trends. Parasitol., 19: Croft S. and Yardley V. (2002). Chemotherapy of leishmaniasis. Curr. Pharm. is. 8: as N., Ranjan., Sinha., Verma N., Lal C., Gupta., Siddiqui N. and Kar S. (2001). randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. J. ssoc. Physicians. India. 49: enerolle P. and ourdoiseau G. (1999). Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the reatment of canine leishmaniasis. J. Vet. Med. 13 (5): Gangneux T.P., Lemenand O., Reinhard Y., Guigen C., Guillouzo C. and Gripon Ph. (2005). In vitro and in vivo permissivity of hepatocytes for Leishmania donovani. J. Eukary. Microbiol. 52 (6): Ferreira I. C., Lonardoni M.V., Machado G. M., Leon L. L., Filho L. G., Pinto L.H. and Goodwine G. (1945). The chemotherapy of experimental leishmaniasis. 11- dose response curve for activity of sodium stibogluconate. Trans. Roy. Soc. Trop. Med. Hyg. 39: (Cited by l-h armani, 1988). Grun J. and Stauber L.. (1957). comparative study of experimental leishmaniasis in the mouse, Mongolian gerbil, hamster, white rat, cotton rat and chinchilla. J. Parasitol. 43: Jawdat S. Z., li N. M., Rifaat L. K., Rutha K. Y. and l-mahdawi S. K. (1985). Sero-epidemiological studies on leishmaniasis in central Iraq. J. iol. Sci. Res. 16 (1): Jha T. K. (2006). rug unresponsiveness and combination therapy for kala-azar. Indian J. Med. Res. 123: Lee G. and Luna H. (1960). Manual of Histologic Staining Method of the rmed Forces Institute of Pathology McGraw Hill ook Company London. PP Mishra J., Saxena. and Singh S. (2007). Chemotherapy of leishmaniasis: Past, present and future. Curr. Med. Chem. 14 (10): Molan. L., Sukkar F. and l-harmni K. I. (1989). Prevalence of visceral leishmaniasis in Iraq during Jpn. J. Parasitol. 38 (5): Mosleh I., Geith E., Natsheh L., Schonian G., botteen N. and Kharabsheh S. (2008). Efficacy of a weekly cryotherapy regimen to treat Leishmania major, cutaneous leishmaniasis. J. cad. ermatol. 58 (4): Murray H.W. (2004). Treatment of visceral leishmaniasis in m. J. Trop. Med. Hyg. 71 (6) Reithinger R., Mohsen M. and Wahid M. (2005). Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, fghanistan: randomized controlled trial. Clin. Infect. is. 40 (8): Riose J. L., Recio M. C. and Villar. (1987). ntimicrobial activity of selected plants employed in the Spanish Mediterranean area. J. Enthopharmacol. 21: Rocha L. G., lmeida J. R., Macedo Ro. and arbosa-filho J. M. (2005). review of natural products with antileishmanial activity. Phytomedicine. 12 (6-7): Rosa M., Mendonca-Filho R., izzo H., Rodrigus I. Soares R. and Loes. C. (2003). ntileishmanial ntimicrobial gents. Chemotherap. 47: Singh R., Pandey H. and Sunder S.( 2006).Visceral leishmaniasis (kala-azar). Indian J. Med. Res. 123: Singh N. (2006). rug resistant mechanisms in clinical isolates of Leishmania donovani. Indian J. Med. Res. 123: Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 25

11 Singh R., Pandey H. and Sunder S. ( 2006). Visceral leishmaniasis (kala-azar). Indian J. Med. Res. 123: Stauber L.., Franchino E. M. and Grun L. (1958). n eight day method for screening compounds against Leishmania donovani in golden hamster. J. Protozool. 5: Sunder S. and Chatterjee M. (2006). Visceral leishmaniasis current therapeutic modalities. Indian J. Med. Res. 123: Tiuman T., Nakamura T., Fihlo P., Cortez. and Nakamura C. amazonensis. cta protozoologica. 44: WHO (2001). ivision of Control of Parasitic iseases. World Health Organization. Geneva, Switzerland. Wright C. W. and Phillipson J.. (1990). Natural products and the development of selective antiprotozoal drugs. Phytotherap. Res. London. 4: Zgaeir K. H. (1999). llopurinol as an antileishmanial agent and itś synergistic effect with sodium stibogluconate in vitro. Iraqi J. Microbiol. 11 (1): Volume 1 Issue 3 (2012) ISSN: X (Print); (Online) 2012 M International. ll rights reserved. 26

Effect of Aqueous Extract of Melia azedarach on the some Biochemical Parameters in the Liver Extract of Infected Mice by Lieshmania donovani

Effect of Aqueous Extract of Melia azedarach on the some Biochemical Parameters in the Liver Extract of Infected Mice by Lieshmania donovani Effect of Aqueous Extract of Melia azedarach on the some Biochemical Parameters in the Liver Extract of Infected Mice by Lieshmania donovani * Kawther Ibrahim Fatah Al-Harmni ** Hussain Ismail AL-Khan

More information

Therapeutic Options for Visceral Leishmaniasis

Therapeutic Options for Visceral Leishmaniasis Drugs (2013) 73:1863 1888 DOI 10.1007/s40265-013-0133-0 REVIEW ARTICLE Therapeutic Options for Visceral Leishmaniasis Begoña Monge-Maillo Rogelio López-Vélez Published online: 30 October 2013 Ó The Author(s)

More information

Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India

Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis Shyam Sundar Banaras Hindu University Varanasi, India History of the Current Epidemic in India & Antimony Resistance 6 Official

More information

Treatment of Cutaneous Leishmaniasis with Allopurinol and Stibogluconate

Treatment of Cutaneous Leishmaniasis with Allopurinol and Stibogluconate 165 Treatment of Cutaneous Leishmaniasis with Allopurinol and S. Martinez, M. Gonzalez, and M. E. Vernaza From the Department of Internal Medicine, University of Cauca, Popayan, and the University Hospital

More information

Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy

Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy IJMS Vol 42, No 5, September 2017 Brief Report Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy Farhad Handjani 1,2, MD; Saeed Reza Yousef 1,2, MD;

More information

Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study

Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study MAJOR ARTICLE Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study S. Sundar, 1 T. K. Jha, 2 C. P. Thakur, 3 M. Mishra, 4 V. P. Singh, 1 and R.

More information

Iranian J Parasitol: Vol. 8, No.3, July -Sep 2013, pp Iranian J Parasitol. Open access Journal at ijpa.tums.ac.ir

Iranian J Parasitol: Vol. 8, No.3, July -Sep 2013, pp Iranian J Parasitol. Open access Journal at   ijpa.tums.ac.ir Iranian J Parasitol: Vol. 8, No.3, July -Sep 2013, pp.396-401 Iranian J Parasitol Tehran University of Medical Sciences Publication http:// tums.ac.ir Open access Journal at http:// ijpa.tums.ac.ir Iranian

More information

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial Tropical Medicine and International Health doi:10.1111/tmi.12015 volume 18 no 1 pp 96 100 january 2013 Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial Shyam Sundar 1,

More information

Drug resistance in Indian visceral leishmaniasis

Drug resistance in Indian visceral leishmaniasis Tropical Medicine and International Health volume6no11pp849±854november2001 Drug resistance in Indian visceral leishmaniasis Shyam Sundar Kala-azar Medical Research Centre, Banaras Hindu University, Varanasi,

More information

References for Application for inclusion of paromomycin in the WHO Model List of Essential Medicines

References for Application for inclusion of paromomycin in the WHO Model List of Essential Medicines 6 (a) Visceral leishmaniasis disease burden. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004:27:305-18. Sundar S, Murray HW. Availability of miltefosine

More information

Laboratory diagnosis of Blood and tissue flagellates

Laboratory diagnosis of Blood and tissue flagellates Laboratory diagnosis of Blood and tissue flagellates (Leishmania and trypanosma) Sarah Alharbi Clinical Laboratory department Collage of Applied Medical Sciences King Saud University Leishmania and trypanosma:

More information

Nanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul)

Nanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul) Faculty of Pharmacy of the University of Lisbon Nanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul) Leishmania in southern Europe. (Duiardin,

More information

Leishmaniasis. CDR R.L. Gutierrez Oct 2014

Leishmaniasis. CDR R.L. Gutierrez Oct 2014 Leishmaniasis CDR R.L. Gutierrez Oct 2014 Overview Protozoan parasite(s) of tissue and WBCs Many species / Many Syndromes (Cutaneous / Visceral) Pathogen: Location - Old World vs. New World Host: Immune

More information

~Trichinella Spiralis:

~Trichinella Spiralis: Musculoskeletal System **Today we are going to talk about the parasites that affect the musculoskeletal system ~Trichinella Spiralis: It s a small nematode that measures to about 2-3mm in length. In general

More information

Medical Science. Jyoti Joshi, Sukhbir Kaur RESEARCH

Medical Science. Jyoti Joshi, Sukhbir Kaur RESEARCH Medical Science The International Weekly journal ISSN 2321 7359 EISSN 2321 7367 RESEARCH To investigate the protective efficacy and immunomodulatory potential of single dose combination of SSG along with

More information

Received: 11 th August-2012 Revised: 14 th Sept-2012 Accepted: 16 th Sept-2012 Research article

Received: 11 th August-2012 Revised: 14 th Sept-2012 Accepted: 16 th Sept-2012 Research article Received: 11 th August-2012 Revised: 14 th Sept-2012 Accepted: 16 th Sept-2012 Research article IN VITRO ANTILEISHMANIAL ACTIVITY OF NYCTANTHES ARBOR-TRISTIS A MEDICINAL TREE Dr. Assistant Professor, Department

More information

Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice

Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1992, p. 1630-1634 Vol. 36, No. 8 0066-4804/92/081630-05$02.00/0 Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice ARMIN KUHLENCORD,1*

More information

Leishmania major Infection

Leishmania major Infection Immunotherapy with Imiquimod Increases the Efficacy of Glucantime Therapy of Leishmania major Infection Ghader Khalili 1, Faramarz Dobakhti 2, Hamid Mahmoudzadeh Niknam 1, Vahid Khaze 1, Fatemeh Partovi

More information

Kala-Azar- Treatment Update

Kala-Azar- Treatment Update JOURNAL OF ADVANCES IN MEDICINE (JAM) DOI: 10.5958/2319-4324.2016.00002.X REVIEW PAPER Kala-Azar- Treatment Update Anup Singh Associate Professor, Department of Medicine, Institute of Medical Sciences,

More information

The Most Common Parasitic Infections In Yemen. Medical Parasitology

The Most Common Parasitic Infections In Yemen. Medical Parasitology The Most Common Parasitic Infections In Yemen Medical Parasitology ﻓﺎﯾز اﻟﺧوﻻﻧﻲ / د 2 : is a vector-borne disease that transmitted by sandflies and caused by obligate intracellular protozoa of the genus

More information

Leishmaniasis. MAJ Kris Paolino September 2014

Leishmaniasis. MAJ Kris Paolino September 2014 Leishmaniasis MAJ Kris Paolino September 2014 Thanks to COL (Ret) Kent Kester MAJ Leyi Lin http://www.niaid.nih.gov/topics/leishmaniasis History Sir William Boog Leishman (1865-1926) Matriculated at the

More information

A Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by. rk39 Test in Sputum Samples

A Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by. rk39 Test in Sputum Samples JCM Accepts, published online ahead of print on 0 June 00 J. Clin. Microbiol. doi:0./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

BIO Parasitology Spring 2009

BIO Parasitology Spring 2009 BIO 475 - Parasitology Spring 2009 Stephen M. Shuster Northern Arizona University http://www4.nau.edu/isopod Lecture 5 Discovery of the Disease In 1924 the Kala-Azar Commission noted that the distribution

More information

Antileishmanial activity of alcoholic extract of (Trigonella foenumgraecum) seeds against ulceration of cutaneous leishmaniasis in vivo

Antileishmanial activity of alcoholic extract of (Trigonella foenumgraecum) seeds against ulceration of cutaneous leishmaniasis in vivo Antileishmanial activity of alcoholic extract of (Trigonella foenumgraecum) seeds against ulceration of cutaneous leishmaniasis in vivo Hind Mahdi Jarallah*, Dawood Salman Mehdi** *Marine Science Center,

More information

Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment

Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment MAJOR ARTICLE Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment Shyam Sundar, Neha Agrawal, Rakesh Arora, Dipti Agarwal, Madhukar Rai, and Jaya Chakravarty

More information

Leishmaniasis: A forgotten disease among neglected people

Leishmaniasis: A forgotten disease among neglected people ISPUB.COM The Internet Journal of Health Volume 11 Number 2 Leishmaniasis: A forgotten disease among neglected people Y Homsi, G Makdisi Citation Y Homsi, G Makdisi. Leishmaniasis: A forgotten disease

More information

HAEMOFLAGELLATES. Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine

HAEMOFLAGELLATES. Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine HAEMOFLAGELLATES Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine Objective Can describe the morphology, life cycle, pathology, diagnosis and prevention of Leishmania spp. and Trypanosoma

More information

Epidemiological, clinical & pharmacological study of antimonyresistant visceral leishmaniasis in Bihar, India

Epidemiological, clinical & pharmacological study of antimonyresistant visceral leishmaniasis in Bihar, India Indian J Med Res 120, September 2004, pp 166-172 Epidemiological, clinical & pharmacological study of antimonyresistant visceral leishmaniasis in Bihar, India C.P. Thakur, S. Narayan* & A. Ranjan* Balaji

More information

Transactions of the Royal Society of Tropical Medicine and Hygiene

Transactions of the Royal Society of Tropical Medicine and Hygiene Transactions of the Royal Society of Tropical Medicine and Hygiene 104 (2010) 225 229 Contents lists available at ScienceDirect Transactions of the Royal Society of Tropical Medicine and Hygiene journal

More information

Original Article Chloroquine in cutaneous leishmaniasis

Original Article Chloroquine in cutaneous leishmaniasis Original Article Chloroquine in cutaneous leishmaniasis Ikramullah Khan, Rifat Yasmin, Iqbal Sidiqui Department of Dermatology, Pakistan Institute of Medical Sciences, Islamabad Abstract Background Chloroquine

More information

Visceral leishmaniasis: an endemic disease with global impact

Visceral leishmaniasis: an endemic disease with global impact Visceral leishmaniasis: an endemic disease with global impact Professor Olivier Lortholary, MD, PhD Department of Infectious and Tropical diseases Hôpital Necker-Enfants Malades Université Paris Descartes

More information

HOST RESISTANCE TO THE KHARTOUM STRAIN OF LEISHMANIA DONOVAN1

HOST RESISTANCE TO THE KHARTOUM STRAIN OF LEISHMANIA DONOVAN1 HOST RESISTANCE TO THE KHARTOUM STRAIN OF LEISHMANIA DONOVAN1 LESLIE A. STAUBER Bzcreazc of BioZogical Research, Rutgers, The State University, New Bn~nswick, New Jersey C OMPARED with trypanosomiasis

More information

Leishmaniasis, Kala Azar(The Black Fever)

Leishmaniasis, Kala Azar(The Black Fever) Leishmaniasis, Kala Azar(The Black Fever) By Lawrence Hall Etiologic agent Protist obligate intracellular parasite, Transmission Vectors Phylum: Euglenozoa (genus Leishmania) Over 21 species that infect

More information

VISERAL LEISHMANIASI S (KALA-AZAR)

VISERAL LEISHMANIASI S (KALA-AZAR) VISERAL LEISHMANIASI S (KALA-AZAR) :OUTLINES DEFINITION. EPIDEMIOLOGY. PARASITE & VECTOR. PATHOLOGY CLINICAL & LIFE CYCLE. PICTURE. COMPLICATIONS. DIAGNOSIS. INVESTIGATIONS. MANAGEMENT TREATMENT S CONTROL.

More information

Immunomodulation of Visceral leishmaniasis with Peganum harmala Seeds Extract in experimental Animals

Immunomodulation of Visceral leishmaniasis with Peganum harmala Seeds Extract in experimental Animals Immunomodulation THE IRAQI POSTEGRADUATE of Visceral leishmaniasis MEDICAL JOURNAL Wassan A. Al-Saidi, etal. Immunomodulation of Visceral leishmaniasis with Peganum harmala Seeds Extract in experimental

More information

Efficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates of Leishmania donovani

Efficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates of Leishmania donovani ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2001, p. 3555 3559 Vol. 45, No. 12 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.12.3555 3559.2001 Copyright 2001, American Society for Microbiology. All Rights

More information

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH IN RATS SUB CHRONIC ORAL TOXICITY WITH NHH 44 Bt-COTTON SEEDS Report for: UNIVERSITY OF AGRICULTURAL SCIENCES AGRICULTURAL RESEARCH STATION DHARWAD-580007 KARNATAKA Guidelines: DBT, Guidelines for Toxicity

More information

Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study

Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study DARU Vol. 17, No. 4 2009 285 Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study *1 Mohebali M., 2 Rezayat M.M., 3

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pentostam Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Stibogluconate equivalent to 100 mg pentavalent antimony in each

More information

Aperito Journal of Bacteriology, Virology and Parasitology. Therapeutic Potential of Nanoparticulate System for Treatment. of Protozoan Infection

Aperito Journal of Bacteriology, Virology and Parasitology. Therapeutic Potential of Nanoparticulate System for Treatment. of Protozoan Infection Aperito Journal of Bacteriology, Virology and Parasitology Received: Sep 19, 2014 Accepted: Oct 08, 2014 Published: Oct 12, 2014 http://dx.doi.org/10.14437/ajbvp-1-102 Editorial Arghya Bandyopadhyay, Aperito

More information

Acta Dermatovenerol Croat 2008;16(2):60-64 CLINICAL ARTICLE

Acta Dermatovenerol Croat 2008;16(2):60-64 CLINICAL ARTICLE 2008;16(2):60-64 CLINICAL ARTICLE Clinical Efficacy of Intramuscular Meglumine Antimoniate Alone and in Combination with Intralesional Meglumine Antimoniate in the Treatment of Old World Cutaneous Leishmaniasis

More information

Departments of Dermatology, Venereology and Leprosy and *Microbiology, Indira Gandhi Medical College, Shimla, India.

Departments of Dermatology, Venereology and Leprosy and *Microbiology, Indira Gandhi Medical College, Shimla, India. Net Study Comparative efþ cacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study Ajeet K.

More information

Leishmaniasis. By Joseph Knight, PA-C. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India.

Leishmaniasis. By Joseph Knight, PA-C. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India. Leishmaniasis By Joseph Knight, PA-C Objectives 1. Identify the two types of leishmaniasis. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India. 3. Discuss how

More information

EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES

EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES ORIGINAL REPORT EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES J. Esmaeili 1, M. Mohebali 1*, G. H. Edrissian 1, S. M. Rezayat 2, M. Ghazi-Khansari 2 and

More information

Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis

Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1998, p. 2542 2548 Vol. 42, No. 10 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Efficacies of KY62 against Leishmania

More information

ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY MAY 2012 ISBN X VOL 13(2)

ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY MAY 2012 ISBN X VOL 13(2) ORIGINAL ARTICLE AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY MAY 2012 ISBN 1595-689X VOL 13(2) AJCEM/201179/21203 -http://www.ajol.info/journals/ajcem COPYRIGHT 2012 AFR. J. CLN. EXPER. MICROBIOL

More information

2.Trichomonas vaginalis

2.Trichomonas vaginalis 2.Trichomonas vaginalis 1. Pathogenic to human &causes vaginitis (trichomoniasis). 2. troph. Is round or pear like in shape, contains 4-6 flagella, all originating from anterior end & only one extend posteriorly.

More information

Laboratory investigation of Cutaneous Leishmaniasis in Karachi

Laboratory investigation of Cutaneous Leishmaniasis in Karachi Laboratory investigation of Cutaneous Leishmaniasis in Karachi Pages with reference to book, From 248 To 250 G.M. Rajpar, M.A. Khan, A. Hafiz ( Department of Microbiology, Jinnah Postgraduate Medical Centre,

More information

Sodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan

Sodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan Sodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan Mamoun Mohammad Al-Athamneh Hiathem Qasem Abu Al-haija Ra ed Smadi Ayman S. Qaqaa Heba

More information

Protozoa from tissues. Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp.

Protozoa from tissues. Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp. Protozoa from tissues Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp. Leishmaniasis Leishmania infantum, Leishmania donovani, in macrophages of man. Female sandflies:

More information

Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics

Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics Clinical dermatology Review article CED Clinical and Experimental Dermatology Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics M. Ameen Royal Free Hospital, Royal

More information

18 : 1. Shyam Sundar, Anup Singh, Arun Shah, Varanasi EPIDEMIOLOGY: DIAGNOSIS OF VL:

18 : 1. Shyam Sundar, Anup Singh, Arun Shah, Varanasi EPIDEMIOLOGY: DIAGNOSIS OF VL: 18 : 1 Visceral leishmaniasis-current scenario Visceral leishmaniasis (VL) is a systemic disease that is fatal if left untreated and is caused by an obligate intracellular protozoan parasite of genus leishmania.

More information

Morphological forms of hemoflagellates

Morphological forms of hemoflagellates Parasitology Lecture: 1 Hemoflagellates (blood and tissue flagellates) *Classification: - Sub-kingdom: Protozoa -Phylum: Sarcomastigophora -Sub-phylum: Mastigiphora -Class: Zoomastigophora د. رائد *Flagellates

More information

Received 23 April 2009/Returned for modification 10 June 2009/Accepted 15 June 2009

Received 23 April 2009/Returned for modification 10 June 2009/Accepted 15 June 2009 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2009, p. 3855 3859 Vol. 53, No. 9 0066-4804/09/$08.00 0 doi:10.1128/aac.00548-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. In

More information

New insights on leishmaniasis in immunosuppressive conditions

New insights on leishmaniasis in immunosuppressive conditions New insights on leishmaniasis in immunosuppressive conditions Javier Moreno Immunoparasitology Unit WHO Collaborative Center for Leishmaniasis Centro Nacional de Microbiología INSTITUTO DE SALUD CARLOS

More information

Necrotizing and suppurative lymphadenitis in Leishmania

Necrotizing and suppurative lymphadenitis in Leishmania Tropical Medicine and International Health VOLUME I NO. 2 PP 243-250 APRIL 1996 Necrotizing and suppurative lymphadenitis in Leishmania major infections A. Gaafar r, A. Ismai13, A. Y. El Kadaro4, Elsir

More information

Cutaneous leishmaniasis in an overseas Filipino worker who responded favorably to oral itraconazole

Cutaneous leishmaniasis in an overseas Filipino worker who responded favorably to oral itraconazole CSE REPORT Cutaneous leishmaniasis in an overseas Filipino worker who responded favorably to oral itraconazole udi, MD 1, ilza ellamy R. Limcangco, MD, FPDS 2, Johannes F, Dayrit, MD, FPDS 2,3 Introduction:

More information

Leishmaniasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course

Leishmaniasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course Leishmaniasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED Acknowledgments LTC James E. Moon, MD Chief, Sleep Trials Branch Walter Reed Army Institute of Research CDR Ramiro

More information

Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar

Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar AA 55M presented with sores on left olecranon and umbilical area Umbilical sores present for 3 weeks Left olecranon lesions for 1 week

More information

SMe. Me NITROIMIDAZOLES FOR VISCERAL LEISHMANIASIS FEXINIDAZOLE AND VL-2098 SHYAM SUNDAR

SMe. Me NITROIMIDAZOLES FOR VISCERAL LEISHMANIASIS FEXINIDAZOLE AND VL-2098 SHYAM SUNDAR SMe O 2 CH 2 O Me ITROIMIDAZOLES FOR VISCERAL LEISHMAIASIS FEXIIDAZOLE AD VL-2098 SHYAM SUDAR Target Product Profile for a CE Optimal Target Profile Target Label VL and PKDL VL Spp All species L. donavani

More information

Crude Ethanolic Extract, Lignoid Fraction and Yangambin from Ocotea duckei (Lauraceae) Show Antileishmanial Activity

Crude Ethanolic Extract, Lignoid Fraction and Yangambin from Ocotea duckei (Lauraceae) Show Antileishmanial Activity Crude Ethanolic Extract, Lignoid Fraction and Yangambin from Ocotea duckei (Lauraceae) Show Antileishmanial Activity Rubens L. Monte Neto a, José M. Barbosa Filho a, Louisa M. A. Sousa b, Petrônio F. Athayde

More information

Mechanistic Studies of Pentamidine Analogs on Leishmania donovani Promastigotes

Mechanistic Studies of Pentamidine Analogs on Leishmania donovani Promastigotes Mechanistic Studies of Pentamidine Analogs on Leishmania donovani Promastigotes Undergraduate Honors Thesis The Ohio State University, College of Pharmacy Division of Medicinal Chemistry and Pharmacognosy

More information

Leishmaniasis impact and treatment access

Leishmaniasis impact and treatment access REVIEW 10.1111/j.1469-0691.2011.03635.x Leishmaniasis impact and treatment access M. den Boer, D. Argaw, J. Jannin and J. Alvar Leishmaniasis Control Programme, WHO/IDM. Av. Appia, Geneva, Switzerland

More information

Cutaneous Leishmaniasis : Global overview

Cutaneous Leishmaniasis : Global overview Cutaneous Leishmaniasis : Global overview Meeting of stakeholders for selected Health R&D Demostration Projects, 7-10 May 2014, WHO, Geneva Dr. Daniel Argaw Dagne, NTD/WHO CSR - DDC AFRO Leishmaniasis

More information

LD Bodies From Blood Buffy Coat: an Easy Approach for Definitive Diagnosis of Visceral Leishmaniasis

LD Bodies From Blood Buffy Coat: an Easy Approach for Definitive Diagnosis of Visceral Leishmaniasis Bangladesh J Med Microbiol 2007; 01 (02): 43-47 Bangladesh Society of Medical Microbiologists Original Article LD Bodies From Blood Buffy Coat: an Easy Approach for Definitive Diagnosis of Visceral Leishmaniasis

More information

Visceral leishmaniasis - current therapeutic modalities

Visceral leishmaniasis - current therapeutic modalities Review Article Indian J Med Res 123, March 2006, pp 345-352 Visceral leishmaniasis - current therapeutic modalities Shyam Sundar & Mitali Chatterjee* Kala-azar Medical Research Center, Department of Medicine,

More information

on November 20, 2018 by guest

on November 20, 2018 by guest AAC Accepts, published online ahead of print on 13 September 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.00985-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Int.J.Curr.Res.Aca.Rev.2017; 5(4):

Int.J.Curr.Res.Aca.Rev.2017; 5(4): International Journal of Current Research and Academic Review ISSN: 2347-3215 (Online) Volume 5 Number 4 (April-2017) Journal homepage: http://www.ijcrar.com doi: https://doi.org/10.20546/ijcrar.2017.504.014

More information

Leishmaniasis chemotherapy challenges and opportunities

Leishmaniasis chemotherapy challenges and opportunities REVIEW 10.1111/j.1469-0691.2011.03630.x Leishmaniasis chemotherapy challenges and opportunities S. L. Croft 1 and P. Olliaro 2,3 1) Faculty of Infectious and Tropical Diseases, London School of Hygiene

More information

POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE

POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE American Journal of Infectious Diseases 10 (2): 50-55, 2014 ISSN: 1553-6203 2014 Science Publication doi:10.3844/ajidsp.2014.50.55 Published Online 10 (2) 2014 (http://www.thescipub.com/ajid.toc) POST

More information

Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis

Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis ISRN Parasitology, Article ID 548010, 4 pages http://dx.doi.org/10.1155/2014/548010 Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis Shyam Sundar,

More information

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use MAJOR ARTICLE Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use Shyam Sundar, 1,a Anup Singh, 1,a Madhukar Rai, 1 Vijay K. Prajapati, 1 Avinash K. Singh,

More information

son. I UNCLASSIFIED DANDL?-90-C-696i F/6 6/15 ML I *Ehhhhhhhhhh

son. I UNCLASSIFIED DANDL?-90-C-696i F/6 6/15 ML I *Ehhhhhhhhhh RD-RISS 886 TESTING EXPERINENTAL COMPOUNDS AGAINST ANERICAN / CUTANEOUS AND NUCOCUTANEOUS LEISHNANIASIS(U) CORNELL UNIY "EDICAL COLL MEN YORK J S KEITHLY JUL 92 I UNCLASSIFIED DANDL?-90-C-696i F/6 6/15

More information

HEPATIC CELL INJURY BY ETHINYL OESTRADIOL ESTROGEN Pandey Govind a*, Pandey S.P. b and Madhuri S. c

HEPATIC CELL INJURY BY ETHINYL OESTRADIOL ESTROGEN Pandey Govind a*, Pandey S.P. b and Madhuri S. c Research Article HEPATIC CELL INJURY BY ETHINYL OESTRADIOL ESTROGEN Pandey Govind a*, Pandey S.P. b and Madhuri S. c a* Ex-Professor & Head of Pharmacology (Pharmacy), presently Officer-In-Charge of Rinder

More information

Therapy of leishmaniasis: Superior efficacies of liposomeencapsulated

Therapy of leishmaniasis: Superior efficacies of liposomeencapsulated Proc. Nati. Acad. Sci. USA Vol. 75, No. 6, pp. 29592963, June 1978 Medical Sciences Therapy of leishmaniasis: Superior efficacies of liposomeencapsulated drugs (antimonial compounds/phospholipids/model

More information

Evaluation of rk28 antigen for serodiagnosis of visceral Leishmaniasis in India

Evaluation of rk28 antigen for serodiagnosis of visceral Leishmaniasis in India ORIGINAL ARTICLE TROPICAL AND PARASITIC DISEASES Evaluation of rk8 antigen for serodiagnosis of visceral Leishmaniasis in India M. Vaish, A. Bhatia, S. G. Reed, J. Chakravarty and S. Sundar ) Department

More information

SEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE

SEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE SEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE 1 Ibrahim A. Al Zubaidy, 2 Hasanain A. Al Saeedi & 3 Ban S.Al-Nasery 1,3 Zoonotic diseases researches unit/ College of Veterinary Medicine/

More information

Post Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels

Post Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels Post Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels A M EL Hassan Institute of Endemic Diseases University of Khartoum Introduction PKDL is a VL related

More information

HISTOPATHOLOGICAL FINDINGS OF LYMPHOID ORGANS DUE TO ADMINISTRATION OF LONG ACTING OXYTETRACYCLINE FORMULATION IN RATS

HISTOPATHOLOGICAL FINDINGS OF LYMPHOID ORGANS DUE TO ADMINISTRATION OF LONG ACTING OXYTETRACYCLINE FORMULATION IN RATS International Journal of Science, Environment and Technology, Vol. 5, No 2, 2016, 737 743 ISSN 2278-3687 (O) 2277-663X (P) HISTOPATHOLOGICAL FINDINGS OF LYMPHOID ORGANS DUE TO ADMINISTRATION OF LONG ACTING

More information

Pathophysiology of Experimental Leishmaniasis: Pattern of Development of Metastatic Disease in the Susceptible Host

Pathophysiology of Experimental Leishmaniasis: Pattern of Development of Metastatic Disease in the Susceptible Host INFCTION AND IMMUNITY, May 1986, p. 364-369 19-9567/86/5364-6$2./ Copyright 1986, American Society for Microbiology Vol. 52, No. 2 Pathophysiology of xperimental Leishmaniasis: Pattern of Development of

More information

I.Khatanbaatar, S.Gantuya1, D.Boldbaatar, others, Journal of agricultural sciences 15 (02): 43-50, 2015

I.Khatanbaatar, S.Gantuya1, D.Boldbaatar, others, Journal of agricultural sciences 15 (02): 43-50, 2015 43 HISTOPATHOLOGICAL CHARACTERIZATION OF L. DONOVANI INFECTION IN RAG2 -/- MICE I.Khatanbaatar 1*, S.Gantuya 1, D.Boldbaatar 1, G.Battsetseg 1 and Y.Matsumoto 2 1-Institute of Veterinary Medicine, MULS,

More information

Cutaneous Leishmaniasis in an Immigrant Saudi Worker: A Case Report

Cutaneous Leishmaniasis in an Immigrant Saudi Worker: A Case Report J HEALTH POPUL NUTR 2014 Jun;32(2):372-376 ISSN 1606-0997 $ 5.00+0.20 INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH CASE STUDY Cutaneous Leishmaniasis in an Immigrant Saudi Worker: A

More information

Resistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine

Resistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 2 Copyright 1988, Institute for Clinical Science, Inc. Resistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine J. C. JARECKI-BLACK,*

More information

Miltefosine for New World Cutaneous Leishmaniasis

Miltefosine for New World Cutaneous Leishmaniasis MAJOR ARTICLE for New World Cutaneous sis J. Soto, 1 B. A. Arana, 4 J. Toledo, 1 N. Rizzo, 4 J. C. Vega, 2 A. Diaz, 4 M. Luz, 1 P. Gutierrez, 1 M. Arboleda, 3 J. D. Berman, 6,a K. Junge, 5 J. Engel, 5

More information

WRAIR- GEIS 'OPERATIONAL CLINICAL INFECTIOUS DISEASE' COURSE

WRAIR- GEIS 'OPERATIONAL CLINICAL INFECTIOUS DISEASE' COURSE Leishmaniasis WRAIR- GEIS 'OPERATIONAL CLINICAL INFECTIOUS DISEASE' COURSE The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as

More information

Jarmila Kliescikova, MD. Leishmaniasis

Jarmila Kliescikova, MD. Leishmaniasis Jarmila Kliescikova, MD Leishmaniasis Leishmania spp. Kinetoplastida More than 20 pathogenic species Disease Cutaneous Transmission: inoculative Amastigotes multiply intracellulary Mucocutaneous Systemic

More information

Eastern Mediterranean Health Journal, Vol. 9, No. 4,

Eastern Mediterranean Health Journal, Vol. 9, No. 4, Eastern Mediterranean Health Journal, Vol. 9, No. 4, 2003 837 Antimony-resistant Leishmania donovani in eastern Sudan: incidence and in vitro correlation M.G. Abdo, 1 W.M. Elamin, 1 E.A.G. Khalil 1 and

More information

Visceral Leishmaniasis combination therapies

Visceral Leishmaniasis combination therapies Best Science for the Most Neglected From patient needs to implementation of new treatments Visceral Leishmaniasis combination therapies Shyam Sundar Institute of Medical Sciences Banaras Hindu University

More information

Blood Smears Only 6 October Sample Preparation and Quality Control 15B-K

Blood Smears Only 6 October Sample Preparation and Quality Control 15B-K NEW YORK STATE Parasitology Proficiency Testing Program Blood Smears Only 6 October 5 The purpose of the New York State Proficiency Testing Program in the category of Parasitology - Blood Smears Only is

More information

Review Article. Management of visceral leishmaniasis: Indian perspective

Review Article. Management of visceral leishmaniasis: Indian perspective Review Article www.jpgmonline.com Management of visceral leishmaniasis: Indian perspective S. Agrawal, M. Rai, S. Sundar Department of Medicine, Institute of Medical Sciences, Banaras Hindu University,

More information

Visceral childhood leishmaniasis in southern Turkey: experience of twenty years

Visceral childhood leishmaniasis in southern Turkey: experience of twenty years The Turkish Journal of Pediatrics 2009; 51: 1-5 Original Visceral childhood leishmaniasis in southern Turkey: experience of twenty years Oğuz Dursun 1, Seyhan Erişir 2, Akif Yeşilipek 3 Divisions of 1

More information

Series Editors Samuel J. Black, University of Massachusetts, Amherst, MA, US.A. J. Richard Seed, University of North Carolina, Chapel Hill, NC, US.A.

Series Editors Samuel J. Black, University of Massachusetts, Amherst, MA, US.A. J. Richard Seed, University of North Carolina, Chapel Hill, NC, US.A. LEISHMANIA World Class Parasites VOLUME 4 Volumes in the World Class Parasites book series are written for researchers, students and scholars who enjoy reading about excellent research on problems of global

More information

Elimination of VL in the Indian subcontinent is it achievable?

Elimination of VL in the Indian subcontinent is it achievable? Elimination of VL in the Indian subcontinent is it achievable? P Das Rajendra Memorial Research Institute, Patna Jorge Alvar DNDi, Geneva Bhawna Sharma DNDi, India Leishmaniasis 350 million at risk worldwide

More information

SUMMARY. Cutaneous leishmaniasis with only skin involvement: single to multiple skin ulcers, satellite lesions and nodular lymphangitis.

SUMMARY. Cutaneous leishmaniasis with only skin involvement: single to multiple skin ulcers, satellite lesions and nodular lymphangitis. SUMMARY Leishmaniasis is a disease affecting predominantly people in the developing countries; 350 million people worldwide are at risk and yearly more than 2 million new cases occur. Leishmaniasis is

More information

Phlebotomus argentipes. Amphotericin B has long been recognized as a powerful anti-kala-azar drug

Phlebotomus argentipes. Amphotericin B has long been recognized as a powerful anti-kala-azar drug A STUDY OF EFFICACY AND ADVERSE DRUG REACTIONS OF CONVENTIONAL AMPHOTERICIN B IN THE TREATMENT OF KALA-AZAR Rajesh Kumar Pandey 1, S. N. Singh 2, Bharat Kumar 3, Kashif Shahnawaz 4 HOW TO CITE THIS ARTICLE:

More information

by author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018

by author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018 Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018 Dr. Monique Wasunna, Director, DNDi Africa Regional Office Presentation Outline 1 2 4 5 Introduction leishmaniasis

More information

New Insights into Diagnosing Leishmaniasis

New Insights into Diagnosing Leishmaniasis New Insights into Diagnosing Leishmaniasis Eric Zini Snow meeting, 13 March 2009 Climate Variability and Visceral Leishmaniasis in Europe WHO/TDR, Jan. 2008 Late Eighties Maroli et al., Trop Med Int Health

More information

Leishmaniasis. caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 )

Leishmaniasis. caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) Leishmaniasis caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) Cutaneous Leishmaniasis Mucocutaneous Leishmaniasis Visceral Leishmaniasis About 12 million people are currently

More information

Leishmaniasis. caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) 皮膚型黏膜型內臟型. Cutaneous Leishmaniasis

Leishmaniasis. caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) 皮膚型黏膜型內臟型. Cutaneous Leishmaniasis Leishmaniasis caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) 皮膚型黏膜型內臟型 Cutaneous Leishmaniasis Mucocutaneous Leishmaniasis Visceral Leishmaniasis About 12 million people

More information

ISPUB.COM. Cutaneous Leishmaniasis in Iran. C Yazdi, M Narmani, B Sadri INTRODUCTION CASE 1 CASE 2

ISPUB.COM. Cutaneous Leishmaniasis in Iran. C Yazdi, M Narmani, B Sadri INTRODUCTION CASE 1 CASE 2 ISPUB.COM The Internet Journal of Infectious Diseases Volume 3 Number 1 Cutaneous Leishmaniasis in Iran C Yazdi, M Narmani, B Sadri Citation C Yazdi, M Narmani, B Sadri. Cutaneous Leishmaniasis in Iran.

More information